Table 3.
Performance of commercial kits using treated saliva as a template for RT-qPCR.
| Commercial kit | Sample size, n | Invalid specimens, n | Concordant to reference, n | Invalid rate, % | Overall agreement, % |
|---|---|---|---|---|---|
| Maccura | 11 | 0 | 11 | 0.00 | 100.00 |
| Fosun | 12 | 1 | 11 | 8.33 | 100.00 |
| Ardent | 11 | 0 | 10 | 0.00 | 90.91 |
| SD Biosensor | 13 | 1 | 11 | 7.69 | 91.67 |
| Biosewoom | 11 | 1 | 8 | 9.09 | 80.00 |
| Fortitude | 11 | 1 | 7 | 9.09 | 70.00 |
| 3S | 10 | 0 | 4 | 0.00 | 40.00 |
| Vazyme | 10 | 4 | 2 | 40.00 | 33.33 |
Rates of the invalid and overall agreement were calculated as compared to results from the reference, Detection Kit for 2019 Novel Coronavirus (2019-nCoV) by Da An Gene Co.